Stock Movers Chevron Rises, Delta Drops, Him & Hers Surges on Novo Obesity Deal That Ends Public Feud
Mar 9, 2026
Talks about a major oil firm in advanced talks to sell a Brazil fuel business stake. Covers airline shares sliding as energy prices spike and analysts cut targets. Discusses a surprising pact that lets a telehealth retailer sell popular weight-loss drugs, ending a public dispute.
AI Snips
Chapters
Transcript
Episode notes
Chevron Rides Oil-Driven Momentum
- Chevron is benefiting from higher oil prices and is on a three-day winning streak after hitting a record high above $192 last week.
- Shares trade around $190 now, leaving room for further market re-pricing as energy names capture immediate upside from oil strength.
Rising Oil Pushes Airlines Toward A Bear Market
- Airlines are under pressure from rising oil, with Delta down over 5% and the S&P Airlines index more than 20% below its late-February high.
- Analysts warn higher fuel costs pose an existential threat to carriers, prompting downgrades despite some upside left versus prior prices.
Novo Ends Feud And Partners With Hims
- Novo Nordisk dropped its lawsuit against Him & Hers and will now sell its obesity drugs on the Hims platform, including Wegovy and Wegovy pills.
- Hims agreed to stop advertising its copies of Novo medicines, turning a public feud into a partnership announcement expected soon.